rs10503818

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_018492.4(PBK):​c.595+2335T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.417 in 152,122 control chromosomes in the GnomAD database, including 13,578 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.42 ( 13578 hom., cov: 33)

Consequence

PBK
NM_018492.4 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.106

Publications

7 publications found
Variant links:
Genes affected
PBK (HGNC:18282): (PDZ binding kinase) This gene encodes a serine/threonine protein kinase related to the dual specific mitogen-activated protein kinase kinase (MAPKK) family. Evidence suggests that mitotic phosphorylation is required for its catalytic activity. The encoded protein may be involved in the activation of lymphoid cells and support testicular functions, with a suggested role in the process of spermatogenesis. Overexpression of this gene has been implicated in tumorigenesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
ESCO2 (HGNC:27230): (establishment of sister chromatid cohesion N-acetyltransferase 2) This gene encodes a protein that may have acetyltransferase activity and may be required for the establishment of sister chromatid cohesion during the S phase of mitosis. Mutations in this gene have been associated with Roberts syndrome. [provided by RefSeq, Jul 2008]
ESCO2 Gene-Disease associations (from GenCC):
  • Roberts-SC phocomelia syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • Roberts syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_018492.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.598 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_018492.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PBK
NM_018492.4
MANE Select
c.595+2335T>C
intron
N/ANP_060962.2
PBK
NM_001278945.2
c.595+2335T>C
intron
N/ANP_001265874.1Q96KB5-2
PBK
NM_001363040.2
c.595+2335T>C
intron
N/ANP_001349969.1Q96KB5-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PBK
ENST00000301905.9
TSL:1 MANE Select
c.595+2335T>C
intron
N/AENSP00000301905.4Q96KB5-1
PBK
ENST00000522944.5
TSL:2
c.595+2335T>C
intron
N/AENSP00000428489.1Q96KB5-2
PBK
ENST00000884617.1
c.595+2335T>C
intron
N/AENSP00000554676.1

Frequencies

GnomAD3 genomes
AF:
0.416
AC:
63306
AN:
152004
Hom.:
13554
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.365
Gnomad AMI
AF:
0.516
Gnomad AMR
AF:
0.492
Gnomad ASJ
AF:
0.268
Gnomad EAS
AF:
0.615
Gnomad SAS
AF:
0.431
Gnomad FIN
AF:
0.371
Gnomad MID
AF:
0.342
Gnomad NFE
AF:
0.429
Gnomad OTH
AF:
0.403
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.417
AC:
63387
AN:
152122
Hom.:
13578
Cov.:
33
AF XY:
0.416
AC XY:
30911
AN XY:
74374
show subpopulations
African (AFR)
AF:
0.365
AC:
15131
AN:
41486
American (AMR)
AF:
0.493
AC:
7537
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.268
AC:
931
AN:
3472
East Asian (EAS)
AF:
0.616
AC:
3181
AN:
5166
South Asian (SAS)
AF:
0.432
AC:
2088
AN:
4830
European-Finnish (FIN)
AF:
0.371
AC:
3922
AN:
10582
Middle Eastern (MID)
AF:
0.340
AC:
100
AN:
294
European-Non Finnish (NFE)
AF:
0.429
AC:
29167
AN:
67980
Other (OTH)
AF:
0.407
AC:
859
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1901
3801
5702
7602
9503
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
602
1204
1806
2408
3010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.438
Hom.:
2506
Bravo
AF:
0.427
Asia WGS
AF:
0.548
AC:
1901
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
3.6
DANN
Benign
0.72
PhyloP100
-0.11
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs10503818;
hg19: chr8-27675747;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.